Hemagglutinin (HA)-based seasonal influenza vaccine (VaxInnate)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHemagglutinin (HA)-based seasonal influenza vaccine (VaxInnate)
Drug Alias Name血凝素(HA)基于季节性流感疫苗 - VaxInnateSTF2.HA1 (SI)VAX-125Flagellin.HuHA
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulantsToll-like receptor agonists
TargetsToll-like receptor
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVaxinnate
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxinnate Co
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A